Ibandronic Acid API is a pharmaceutical-grade bisphosphonate used in the prevention and treatment of osteoporosis, particularly in postmenopausal women, and other metabolic bone disorders. It works by selectively inhibiting osteoclast-mediated bone resorption, helping increase bone mineral density and significantly reducing the risk of vertebral fractures.
Ibandronic Acid is widely formulated into oral and injectable dosage forms for long-term management of osteoporosis. Its potent antiresorptive activity and well-established clinical efficacy make it an important active pharmaceutical ingredient for bone health therapies.
Manufactured under WHO-GMP-certified facilities, our Ibandronic Acid API delivers exceptional purity, stability, and batch-to-batch consistency. Every batch undergoes stringent quality testing and is supplied with complete regulatory documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and Product Specifications.
Ibandronic Acid API is used in pharmaceutical formulations for the prevention and treatment of osteoporosis and other bone-related disorders.
It inhibits osteoclast-mediated bone resorption, helping maintain bone strength and reducing the risk of fractures.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation.
Yes. We supply Ibandronic Acid API in commercial quantities with worldwide export support.
Get Bulk Quote via WhatsApp